Literature DB >> 19025548

Are cortical spreading depression and headache in migraine causally linked?

J Wolthausen1, S Sternberg, C Gerloff, A May.   

Abstract

During the past few decades, much controversy has surrounded the pathophysiology of migraine. Cortical spreading depression (CSD) is widely accepted as the neuronal process underlying visual auras. It has been proposed that CSD can also cause the headaches, at least in migraine with aura. We describe three patients, each fulfilling the International Headache Society criteria for migraine with aura, who suffered from headaches 6-10 days per month. Two patients were treated with flunarizine and the third patient with topiramate for the duration of 4 months. All patients reported that aura symptoms resolved completely, whereas the migraine headache attacks persisted or even increased. These observations question the theory that CSD (silent or not) is a prerequisite for migraine headaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19025548     DOI: 10.1111/j.1468-2982.2008.01713.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  11 in total

Review 1.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

Review 2.  Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations.

Authors:  Daniela Pietrobon; Michael A Moskowitz
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

Review 3.  Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.

Authors:  Ann C Raddant; Andrew F Russo
Journal:  Expert Rev Mol Med       Date:  2011-11-29       Impact factor: 5.600

Review 4.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Authors:  Till Sprenger; M Viana; C Tassorelli
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 5.  Advanced neuroimaging of migraine.

Authors:  Todd J Schwedt; David W Dodick
Journal:  Lancet Neurol       Date:  2009-06       Impact factor: 44.182

6.  Genetic TPH2 variants and the susceptibility for migraine: association of a TPH2 haplotype with migraine without aura.

Authors:  Alexander Jung; Andreas Huge; Gregor Kuhlenbäumer; Steffi Kempt; Tanja Seehafer; Stefan Evers; Klaus Berger; Martin Marziniak
Journal:  J Neural Transm (Vienna)       Date:  2010-08-26       Impact factor: 3.575

Review 7.  The Use of Antioxidants in the Treatment of Migraine.

Authors:  Marta Goschorska; Izabela Gutowska; Irena Baranowska-Bosiacka; Katarzyna Barczak; Dariusz Chlubek
Journal:  Antioxidants (Basel)       Date:  2020-01-28

Review 8.  Migraine pathogenesis and state of pharmacological treatment options.

Authors:  Till Sprenger; Peter J Goadsby
Journal:  BMC Med       Date:  2009-11-16       Impact factor: 8.775

9.  Three-dimensional visualization with large data sets: a simulation of spreading cortical depression in human brain.

Authors:  Korhan Levent Ertürk; Gökhan Şengül
Journal:  J Biomed Biotechnol       Date:  2012-10-31

10.  Does primary headache type influence secondary headache symptoms?

Authors:  Aaron McMurtray; Erin Saito
Journal:  J Neurosci Rural Pract       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.